Implementierungsleitfaden Therapieziele Onkologie
1.0.0-ballot - Ballot
Germany
Implementierungsleitfaden Therapieziele Onkologie - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
{
"resourceType" : "Goal",
"id" : "TherapiezielCRCErhaltung",
"meta" : {
"profile" : [
🔗 "https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/onko-therapy-goal"
]
},
"language" : "de",
"text" : {
"status" : "extensions",
"div" : "<div xml:lang=\"de\" lang=\"de\"><hr/><p><b>German</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: Goal TherapiezielCRCErhaltung</b></p><a name=\"TherapiezielCRCErhaltung\"> </a><a name=\"hcTherapiezielCRCErhaltung\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-onko-therapy-goal.html\">Onkologisches Therapieziel</a></p></div><blockquote><p><b>Onkologische Therapieintention (Extension)</b></p><ul><li>hauptintention: <span title=\"Codes:{http://snomed.info/sct 363676003}\">Palliative intent</span></li><li>phase: <span title=\"Codes:{http://snomed.info/sct 1345242003}\">Maintenance antineoplastic therapy</span></li></ul></blockquote><blockquote><p><b>Goal: Related Goal</b></p><ul><li>type: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/goal-relationship-type predecessor}\">Predecessor</span></li><li>target: <a href=\"Goal-TherapiezielCRCLebensverlaengerung.html\">Goal: extension = ,,,; lifecycleStatus = active; achievementStatus = In Progress; category = Lebensverlängerung,Symptomkontrolle / Palliation; priority = High Priority; description = ; start[x] = 2026-02-10</a></li></ul></blockquote><p><b>lifecycleStatus</b>: Proposed</p><p><b>category</b>: <span title=\"Codes:{https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/onko-therapy-goal-type lebensverlaengerung}\">Lebensverlängerung</span>, <span title=\"Codes:{https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/onko-therapy-goal-type lebensqualitaet}\">Lebensqualität</span></p><p><b>description</b>: <span title=\"Codes:\">Erhalt des Therapieansprechens bei reduzierter Toxizität (Erhaltungstherapie) nach erfolgreicher Induktion.</span></p><p><b>subject</b>: <a href=\"Patient-PatientinCRC.html\">Erika Musterfrau Female, DoB: 1961-09-12</a></p><p><b>expressedBy</b>: <a href=\"Practitioner-OnkologinCRC.html\">Practitioner Petra Musterarzt </a></p><p><b>addresses</b>: <a href=\"Condition-ConditionCRC.html\">Condition Bösartige Neubildung: Kolon, nicht näher bezeichnet</a></p></div>"
},
"extension" : [
{
"extension" : [
{
"url" : "hauptintention",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "363676003",
"display" : "Palliative intent"
}
]
}
},
{
"url" : "phase",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "1345242003",
"display" : "Maintenance antineoplastic therapy"
}
]
}
}
],
"url" : "https://bih-cei.de/fhir/therapieziele-onkologie/StructureDefinition/onko-therapy-intent"
},
{
"extension" : [
{
"url" : "type",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/goal-relationship-type",
"code" : "predecessor",
"display" : "Predecessor"
}
]
}
},
{
"url" : "target",
"valueReference" : {
🔗 "reference" : "Goal/TherapiezielCRCLebensverlaengerung"
}
}
],
"url" : "http://hl7.org/fhir/StructureDefinition/goal-relationship"
}
],
"lifecycleStatus" : "proposed",
"category" : [
{
"coding" : [
{
"system" : "https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/onko-therapy-goal-type",
"code" : "lebensverlaengerung",
"display" : "Lebensverlängerung"
}
]
},
{
"coding" : [
{
"system" : "https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/onko-therapy-goal-type",
"code" : "lebensqualitaet",
"display" : "Lebensqualität"
}
]
}
],
"description" : {
"text" : "Erhalt des Therapieansprechens bei reduzierter Toxizität (Erhaltungstherapie) nach erfolgreicher Induktion."
},
"subject" : {
🔗 "reference" : "Patient/PatientinCRC"
},
"expressedBy" : {
🔗 "reference" : "Practitioner/OnkologinCRC"
},
"addresses" : [
{
🔗 "reference" : "Condition/ConditionCRC"
}
]
}